Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 2:59 PM
Ignite Modification Date:
2025-12-25 @ 1:23 PM
NCT ID:
NCT05399459
Population Description:
Safety analysis set consisted of participants in the enrolled analysis set (participants who signed an informed consent form and were assigned a participant identification number) and who had taken the study drug (rimegepant 25 mg, rimegepant 75 mg, or placebo). One participant who was randomized to the placebo group received rimegepant 25 mg. This participant in safety analysis set was included in rimegepant 25 mg arm and not in placebo arm.
Study:
NCT05399459
Study Brief:
Results Section:
NCT05399459